Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Understanding methamphetamine's (METH) dose-dependent neurochemical effects is crucial for behavioral pathology research.
• Existing human studies primarily focus on high-dose, long-term METH abuse, leaving lower-dose patterns under-characterized.

Purpose of the Study:

• To characterize METH blood concentrations in individuals with non-dependent, lower-dose exposure.
• To establish a basis for investigating potential brain pathology associated with these distinct METH exposure patterns.

Main Methods:

• Blood samples were collected from 105 individuals testing positive for stimulants.
• METH concentrations were quantified using gas chromatography-mass spectrometry (GC-MS).
• Pharmacokinetic modeling estimated METH body burdens and simulated exposure patterns.

Main Results:

• METH blood concentrations were predominantly in the low micromolar range (0.1-11.1 microM), with median and mean values of 1.3 microM and 2 microM, respectively.
• Estimated median initial METH body burden was 52 mg.
• Modeled low-dose METH exposure maintained blood concentrations between 1-4 microM over a simulated 4-day period.

Conclusions:

• The study identifies a distinct METH exposure pattern characterized by lower blood concentrations compared to high-dose abuse.
• These findings provide a rationale for further research into the neurobiological consequences of lower-dose METH exposure.